The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification

A Rowland, JO Miners, PI Mackenzie - … journal of biochemistry & cell biology, 2013 - Elsevier
Human UDP-glucuronosyltransferase (UGT) exists as a superfamily of 22 proteins, which
are divided into 5 families and 6 subfamilies on the basis of sequence identity. Members of …

Opioid metabolism

HS Smith - Mayo Clinic Proceedings, 2009 - Elsevier
Clinicians understand that individual patients differ in their response to specific opioid
analgesics and that patients may require trials of several opioids before finding an agent that …

UDP-glucuronosyltransferases and clinical drug-drug interactions

TKL Kiang, MHH Ensom, TKH Chang - Pharmacology & therapeutics, 2005 - Elsevier
UDP-glucuronosyltransferase (UGT) enzymes catalyze the conjugation of various
endogenous substances (eg, bilirubin) and exogenous compounds (eg, drugs). The human …

The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies

SU Yasuda, L Zhang, SM Huang - Clinical Pharmacology & …, 2008 - Wiley Online Library
Ethnicity is one factor that may account for the observed differences in both
pharmacokinetics (PK) and pharmacodynamics (PD) of drugs, resulting in variability in …

Pharmacogenomics of human UDP-glucuronosyltransferase enzymes

C Guillemette - The pharmacogenomics journal, 2003 - nature.com
ABSTRACT UDP-glucuronosyltransferase (UGT) enzymes comprise a superfamily of key
proteins that catalyze the glucuronidation reaction on a wide range of structurally diverse …

Differences between opioids: pharmacological, experimental, clinical and economical perspectives

AM Drewes, RD Jensen, LM Nielsen… - British journal of …, 2013 - Wiley Online Library
Clinical studies comparing the response and side effects of various opioids have not been
able to show robust differences between drugs. Hence, recommendations of the regulatory …

CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

JM Rae, S Drury, DF Hayes, V Stearns… - Journal of the …, 2012 - academic.oup.com
Background Adjuvant tamoxifen therapy substantially decreases the risk of recurrence and
mortality in women with hormone (estrogen and/or progesterone) receptor–positive breast …

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes

AK Daly, GP Aithal, JBS Leathart, RA Swainsbury… - Gastroenterology, 2007 - Elsevier
Background & Aims: Diclofenac is a widely used nonsteroidal anti-inflammatory drug and is
among the most common drugs causing idiosyncratic hepatotoxicity in several recent series …

Pharmacogenetics of opioids

AA Somogyi, DT Barratt… - Clinical Pharmacology & …, 2007 - Wiley Online Library
Opioids are used for acute and chronic pain and dependency. They have a narrow
therapeutic index and large interpatient variability in response. Genetic factors regulating …

Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case–control study

P Madadi, CJD Ross, MR Hayden… - Clinical …, 2009 - Wiley Online Library
A large number of women receive codeine for obstetric pain while breastfeeding. Following
a case of fatal opioid poisoning in a breastfed neonate whose codeine prescribed mother …